Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000034960Phase 4Recruiting
Phase 4, open-label, single-arm trial of Guilingji in Fragility, sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Frailty scale assessment. Started Aug 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000034960.